Pharmaceuticals, Patents & Profits: South deprived of life-saving drugs
TRIPS and pharmaceuticals: A case of corporate profits over public health (Cecilia Oh/TWN)
the obligations it imposes on member countries of the trade body to recognise
and strengthen patent protection on pharmaceuticals, the World Trade Organisation's
Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS)
is denying patients in the developing world access to life-saving essential
medicines. The countries of the South now find themselves ranged against
Northern governments and powerful pharmaceutical lobbies in their fight,
at the WTO and beyond, to ensure public health takes precedence over corporate
Geneva 2000: The battle of patents vs affordable medicines (Cecilia Oh/TWN)
key issue at the 26 June-1 July Special Session of the UN General Assembly
(UNGASS) on Social Development was the right of people to essential medicines
at affordable prices, and how this right is being undermined by patents
and the intellectual property rights regime established by the WTO’s TRIPS
Agreement. Cecilia Oh reports on the debate on this issue at UNGASS and
at an NGO event organised in the week of the Special Session.
Globalisation and equitable access to essential drugs (Ellen 't Hoen)
there are a number of factors, such as high cost, insufficient production,
and lack of research and development, which have ontributed to denying
equitable access to drugs to millions in the Third World, it is the international
trade regulations arising from globalisation that may prove to be the
biggest obstacle to such access. Ellen 't Hoen considers these impediments
to access and suggests some new global approaches to overcome them.
Open letter to the WTO member countries on TRIPS and access to health care technology
On the eve of last year's WTO Ministerial Conference in Seattle,
Medicins Sans Frontieres, Health Action International and Consumer
Project on Tchnology issued the following open letter to members of
the multilateral trade body urging the latter to consider initiating
moves, both within and beyond the framework of the TRIPS Agreement,
to promote equitable access to health care.
Patent rights vs patient rights
social activists, public health advocates, government officials
and politicians from Africa, Asia, South and North America, Australia
and Europe met in Oslo on 22-24 May 2000 at a workshop entitled 'Patent
Rights vs. Patient Rights' to discuss access to essential drugs, including
treatment for AIDS. They issued the following call for access to basic
technologies and essential drugs.
Africa shuns US move allowing access to cheaper AIDS drugs
countries are not exactly queuing up at the US Trade Department to take
advantage of flexible patent regulations allowing them to access cheaper
AIDS drugs. The reason may be due to mixed signals coming out of Washington,
says Gumisai Mutume.
Killing Africa with kindness (R.Mokhiber & R. Weissman)
Mokhiber and Robert Weissman uncover the perils and pitfalls behind a
US government move to provide loans to African countries for the purchase
of AIDS drugs.
How WTO/TRIPS threatens the Indian pharmaceutical industry (R.Gerster)
pharmaceutical industry is a success story providing employment for millions
and ensuring that essential drugs at affordable prices are available to
the vast population of this sub-continent. However, the new 'trade' rules
of the World Trade Organisation now pose a serious threat to the industry
and to the millions who are dependent on it for their health and livelihood.
taking our tablets (no one else's) (Gregory Palast)
response to Africa's AIDS crisis is a chilling reminder of where power
lies in the global economy.
MAIN | ONLINE BOOKSTORE
| HOW TO ORDER